|
May 2
|
AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
|
|
May 1
|
Amgen investors await weight-loss drug data
|
|
May 1
|
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
|
|
Apr 30
|
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
|
|
Apr 30
|
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
|
|
Apr 30
|
Sandoz reaches agreement with Amgen over patent dispute
|
|
Apr 29
|
AMGEN ANNOUNCES WEBCAST OF 2024 FIRST QUARTER FINANCIAL RESULTS
|
|
Apr 29
|
What's in the Cards for Amgen (AMGN) This Earnings Season?
|
|
Apr 29
|
Insights Into Amgen (AMGN) Q1: Wall Street Projections for Key Metrics
|
|
Apr 26
|
A Big Week For The Stock Market: Apple, Amazon, Big Pharma And The Fed
|
|
Apr 26
|
AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY
|
|
Apr 25
|
20 Fastest Growing Health Tech Companies in the World
|
|
Apr 25
|
Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for
|
|
Apr 25
|
Spring Awakening: 3 Dow Stocks Emerging from Hibernation
|
|
Apr 24
|
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
|
|
Apr 22
|
10 Best Performing Biotech ETFs in 2024
|
|
Apr 19
|
The Dividend Goldmine: 3 Shining Stocks With Growing Payouts
|
|
Apr 17
|
Sell These 3 Blue-Chip Stocks Before the Next Earnings Stumble
|
|
Apr 17
|
Coming FDA Approvals Could Send These 3 Drug Stocks Soaring
|
|
Apr 17
|
Can This High-Yield Dividend Stock Keep Beating the S&P 500?
|